Otolaryngology, ENT & Sinus News Provided by Dallas ENT

Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution - Corrected Proof

June 22, 2011, 12:00 pm by American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press

Abstract: Background: T1 and T2 tonsillar squamous cell cancer with limited neck disease can be managed with single-modality radiation or surgery. Over 11 years, 17 patients underwent radical tonsillectomies; and 33 patients underwent radiation-based treatments for T1 and T2 and N0 to N2a tonsil cancer. Patients were intended to receive single-modality treatment based on presentation; however, some ultimately received adjuvant treatments.Methods: A retrospective chart review to compare overall survival (OS), disease-specific survival (DSS), and locoregional control (LRC) between the groups was used.Results: In surgical group, of 17 patients, 11 underwent surgery alone, 3 underwent surgery and radiation, and 3 underwent surgery with concurrent chemoradiation. Five-year OS for the surgical and radiation groups was 93% and 72%, respectively (no significance achieved). Five-year DSS rates (93% and 80%) and LRC (69% and 89%) similarly did not yield any significant difference.Conclusion: Surgery remains a viable option in the management of T1 and T2 tonsillar cancers with comparable LRC, OS, and DSS.

Read the full article


More from American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press

A Case-Control Analysis of Survival Outcomes in Sinonasal Carcinosarcoma
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: October 30, 2014, 12:00 pm
Carcinosarcoma is a rare malignant tumor of mixed epithelial and mesenchymal origin. In the head and neck, carcinosarcoma most commonly affects the salivary glands. Primary sinonasal carcinosarcoma (SN-CS) is exceedingly rare.

Three Week Loading for the Baha BI-300® Implant System
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: October 30, 2014, 12:00 pm
The timing of loading of titanium craniofacial implants is dependent upon implant characteristics, host factors, and the bonding of titanium oxide and bone referred to as osseointegration. The purpose of this feasibility

Intratympanic Dexamethazone versus High Dosage of Betahistine in the Treatment of Intractable Unilateral Meniere Disease
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: October 29, 2014, 12:00 pm
The objective of our randomized, double-blind study was to compare the effectiveness of intratympanic (IT) dexamethasone versus high-dosage of betahistine in the treatment of patients with intractable unilateral Meniere disease (MD).

Prognostic factors of head and neck sarcomas
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: October 25, 2014, 12:00 pm
Thank you for your interest in our study. Your comments highlight a number of issues that we feel require clarification.

Repair of Tegmen Defect Using Cranial Particulate Bone Graft
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: October 23, 2014, 12:00 pm
Bone paté is used to repair cranial bone defects. This material contains bone-dust collected during the high-speed burring of the cranium. Clinical and experimental studies of bone dust, however, have shown that

 

NOTICE: The Dallas ENT web site "Otolaryngology ENT Industry News" has data and links presented by way of the above mentioned RSS news feeds. We offer this industry news for your convenience and education. Dallas ENT does not review the information provided in this section. Dallas ENT does not assume any endorsement or present these third-party feeds and links as Dallas ENT belief or in conjunction with Dallas ENT whatsoever. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by Dallas ENT. For more information, please see our disclaimer.